Termination of Pregnancy: Misoprostol Versus Prostaglandin E2
DOI:
https://doi.org/10.51253/pafmj.v73i6.11376Keywords:
Misoprostol, Prostaglandins, Termination of pregnancyAbstract
Objective: To compare the efficacy of vaginal Misoprostol and vaginal prostaglandin E2 in termination of pregnancy.
Study Design: Quasi-experimental study.
Place and Duration of Study: Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Islamabad, Pakistan, from
Apr to Oct 2021.
Methodology: After taking informed consent, a total of 80 women between the age of 20-40 years were included in the study
for termination of pregnancy. Molar or ectopic pregnancy, signs of septic abortion, Chronic Liver Disease, and bleeding
disorders were excluded. In group A, a 200µgm tablet of Misoprostol was inserted intravaginal every 6 hours, a total of 4
doses, while in group B patients, a PGE2 3 mg tablet was inserted intravaginal, a total of 4 doses. All patients in both groups
were evaluated after 24 hours, at which efficacy was noted.
Results: The mean age of women in Group-A was 27.18±3.81 years, and in Group-B was 27.18±4.96 years. The mean
gestational age in Group-A was 11.83±3.24 weeks, and in Group-B was 12.20±3.30 weeks. In this study, efficacy (complete
expulsion of the fetus within 24 hours of medication) was seen in 37 (92.50%) women in Group-A (Vaginal Misoprostol) and
29 (72.50%) women in Group-B (Vaginal prostaglandin E2) with a p-value of 0.019.
Conclusion: This study concluded that the efficacy of vaginal Misoprostol is better in termination of pregnancy as compared to
vaginal prostaglandin E2.
Downloads
Metrics
References
Tanwar M, Zuthsi V. A prospective randomized comparison of
mifepristone with Misoprostol and prostaglandin E2 gel with
Misoprostol for medical termination of pregnancy between 13-
week of gestation. Int J Reprod Contracept Obstet Gynecol
; 9(9): 3654-3660.http://doi.org/10.18203/2320-1770.ijrcog20203835
Devi K, Aftab S, Baloch H, Kumari D, Ayaz S. Role of
Misoprostol 4 hourly versus 6 hourly in medical termination of
pregnancy in 2nd trimester. Professional Med J 2021; 28(11): 1645-
https://doi.org/10.29309/TPMJ/2021.28.11.6285
Shoja S, Yousefi-Sharami SR, Shahgheibi S, Zand-Vakili F, Zare S,
Roshani D, et al. Contrastive analysis of vaginal Misoprostol
and foley catheter in cervical ripening and labor induction. J
Obstet Gynecol Cancer Res 2022; 4(3): 105-110.
https://doi.org/10.30699/jogcr.4.3.105
Nisa S, Razaq F, Nisa S. Comparison of efficacy of Misoprostol 4
hourly with Misoprostol 6 hour for medical termination of
pregnancy in second trimester. Professional Med J 2020; 27(1):
-51. https://doi.org/10.29309/TPMJ/2019.27.01.3169
El-Sayed YA, Behery MM, Abdel Fatah MT. Administration of
Misoprostol sublingual versus vaginal for the termination of
second trimester missed miscarriage. Zagazig Uni Med J 2021;
(4): 631-637. https://doi.org/10.21608/zumj.2019.15870.1420
Serdinšek T, Reljič M, Kovač V. Medical management of
first trimester missed miscarriage: the efficacy and complication
rate. J Obstet Gynaecol 2019; 39(5): 647-651.
https://doi.org/0.1080/01443615.2018.1535577
Majeed F, Al-Ani H. Comparison between different dose
regimens of Misoprostol in termination of early pregnancy.
Tikrit J Pharmac Sci 2019; 14(1): 41-51.
https://doi.org/10.25130/tjphs.2019.14.1.5.41.51
Desouky E, Elsayed AA. Randomized controlled trial between
vaginal Misoprostol alone versus weighted intrauterine foley’s
catheter and vaginal Misoprostol in termination of midtrimester abortion. Evidence Based Women's Health J 2021; 11(2):
-145. https://doi.org/10.21608/EBWHJ.2019.17469.1024
Surrago EJ, Robins J. Midtrimester pregnancy termination by
intravaginal administration of prostaglandin E2. Contraception
; 26: 285-294. https://doi.org/10.1016/0010-7824(82)90076-2.
Carbonell J. Varela L.Velazco A. Early abortion with 800
microgram of Misoprostol by the vaginal route. Contrcep 1999;
: 219-225. https://doi.org/10.1016/s0010-7824(99)00032-3
Nagina FL, Iffat J, Samia S, Tabassum S, Khadija B. Therapeutic
termination of second trimester pregnancies with low dose
Misoprostol . J Coll Physicians Surg Pak 2006; 16: 464-467.
Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH.
Second-trimester pregnancy termination: comparison of three
different methods. J Obstet Gynaecol 2003; 23(4): 407-411.
https://doi.org/0.1080/0144361031000120923
Agrawal NR, Munday A, Sovena J. Misoprostol (PGE1) versus
dinoproston (PGE2) in termination of second trimester pregnancy. J Obstet Gynecol India. 2002; 52(1): 79-81.
Wildshut H, Both MI. Medical methods for midtrimester
termination of pregnancy. Cochrane Database Syst Rev 2011;
(1): 5216. https://doi.org/10.1002/14651858.CD005216.pub2
Bugalho A, Bique C, Almeida L, Bergstrom S. Pregnancy
interruption by vaginal Misoprostol . Gynecol Obstet Invest
; 36(1): 226-229. https://doi.org/10.1159/000292634
Kumar N, Haas DM, Weeks AD. Misoprostol for labour
induction. Best Practice Res Clin Obstet Gynaecol 2021; 77: 53-63.
https://doi.org/0.1016/j.bpobgyn.2021.09.003
Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y, et al.
Mifepristone and Misoprostol versus Misoprostol alone for the
management of missed miscarriage (MifeMiso): a randomised,
double-blind, placebo-controlled trial. Lancet 2020; 396(10253):
-778. https://doi.org/10.1016/S0140-6736(20)31788-8
Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson
MD, Fisher J, et al Miscarriage matters: the epidemiological,
physical, psychological, and economic costs of early pregnancy
loss. Lancet 2021; 397(10285): 1658-1667.
https://doi.org/10.1016/S0140-6736(21)00682-6.
Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002
consecutive cases. Contracept 2004; 69(1): 51-58.
https://doi.org/10.1016/j.contraception.2003.09.006
Gupta N, Mittal S. Is mifepristone needed for second trimester
termination of pregnancy? J Turkish German Gynecol Assoc
; 8(1): 58-66.
Downloads
Published
How to Cite
Issue
Section
